1. Home
  2. BMRN vs WTRG Comparison

BMRN vs WTRG Comparison

Compare BMRN & WTRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • WTRG
  • Stock Information
  • Founded
  • BMRN 1996
  • WTRG 1901
  • Country
  • BMRN United States
  • WTRG United States
  • Employees
  • BMRN N/A
  • WTRG N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • WTRG Water Supply
  • Sector
  • BMRN Health Care
  • WTRG Utilities
  • Exchange
  • BMRN Nasdaq
  • WTRG Nasdaq
  • Market Cap
  • BMRN 10.0B
  • WTRG 10.9B
  • IPO Year
  • BMRN 1999
  • WTRG N/A
  • Fundamental
  • Price
  • BMRN $51.05
  • WTRG $39.35
  • Analyst Decision
  • BMRN Buy
  • WTRG Buy
  • Analyst Count
  • BMRN 19
  • WTRG 7
  • Target Price
  • BMRN $90.26
  • WTRG $44.33
  • AVG Volume (30 Days)
  • BMRN 2.8M
  • WTRG 2.3M
  • Earning Date
  • BMRN 10-27-2025
  • WTRG 11-04-2025
  • Dividend Yield
  • BMRN N/A
  • WTRG 3.47%
  • EPS Growth
  • BMRN 59.53
  • WTRG 20.57
  • EPS
  • BMRN 2.68
  • WTRG 2.40
  • Revenue
  • BMRN $3,094,001,000.00
  • WTRG $2,379,887,000.00
  • Revenue This Year
  • BMRN $13.32
  • WTRG $13.46
  • Revenue Next Year
  • BMRN $7.51
  • WTRG $5.45
  • P/E Ratio
  • BMRN $19.34
  • WTRG $16.47
  • Revenue Growth
  • BMRN 12.39
  • WTRG 21.35
  • 52 Week Low
  • BMRN $51.00
  • WTRG $33.18
  • 52 Week High
  • BMRN $73.51
  • WTRG $42.37
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 38.70
  • WTRG 47.04
  • Support Level
  • BMRN $51.80
  • WTRG $37.86
  • Resistance Level
  • BMRN $53.49
  • WTRG $40.12
  • Average True Range (ATR)
  • BMRN 1.84
  • WTRG 0.95
  • MACD
  • BMRN -0.11
  • WTRG -0.21
  • Stochastic Oscillator
  • BMRN 4.80
  • WTRG 32.93

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About WTRG Essential Utilities Inc.

Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.

Share on Social Networks: